Trial intelligence / Profile preview

Doxycycline ± Fuke Qianjin Capsule for Chronic Endometritis in IVF/ICSI Patients

ChiCTR2500106121Phase 4Not yet recruiting

Sponsor
West China Second University Hospital
Start
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of doxycycline and Fuke Qianjin in endometritis (2 arms), sponsored by West China Second University Hospital. Primary endpoint: clinical cure rate of chronic endometritis. Planned start Jul 2025; status: not yet recruiting.

02

Drugs

doxycyclineFuke Qianjin
03

Conditions

endometritis

Beyond the preview

Go deeper on ChiCTR2500106121.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500106121.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call